OTHER GROUP COMPANIES
market

Q1FY23 Preview: Apollo Hospitals: Revenue seen at Rs37,400 million; PAT at Rs1,500 million

High base effect of the June quarter of the previous year will be seen

August 10, 2022 3:01 IST | India Infoline News Service
Result date: 11th August
Recommendation: Buy
Target price: Rs4,850


Apollo Hospitals is likely to witness improvement in occupancy of non-COVID patients in the June quarter. Pharmacy business could post flattish growth in the quarter. Revenue could dip 0.5% over the year-ago quarter. This decline is because of the high base effect of June quarter of the previous year. EBITDA could decline 8.05%, on the back of a high base.

Profit After Tax (PAT) could fall 47.53% over the year-ago quarter, owing to lower other income. 

Key management insights to look into:
  • Growth outlook for key business segments
  • Traction of Apollo 24/7
  • Improvement in international patients segment in the hospitals business
Rs. Million June 2022 estimates Y-o-Y
Revenue  37,400 (0.5%)
EBITDA 4,780 (8.05%)
PAT  1,500 (47.53%)
Source: Brokerage Reports

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity